| scholarly article | Q13442814 |
| P50 | author | Aneta Kowal | Q82177322 |
| Piotr Kuśnierczyk | Q82758549 | ||
| Renata Jankowska | Q109616169 | ||
| P2093 | author name string | Andrzej Wiśniewski | |
| P2860 | cites work | Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition) | Q81303406 |
| Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population | Q84574383 | ||
| Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease | Q86540077 | ||
| Nomenclature for factors of the HLA system, 2010 | Q24605855 | ||
| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition) | Q28248985 | ||
| Interferons, immunity and cancer immunoediting | Q28270336 | ||
| Beyond the increasing complexity of the immunomodulatory HLA-G molecule | Q28272361 | ||
| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma | Q28303718 | ||
| Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production | Q28350682 | ||
| Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
| Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). | Q33299169 | ||
| Variation in the HLA-G Promoter Region Influences Miscarriage Rates | Q33904835 | ||
| HLA-G gene repression is reversed by demethylation | Q33963997 | ||
| Non-classical transcriptional regulation of HLA-G: an update | Q34017943 | ||
| A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution | Q34188250 | ||
| Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association | Q34491478 | ||
| The revised TNM staging system for lung cancer. | Q34956972 | ||
| HLA-G and IL-10 expression in human cancer--different stories with the same message | Q35621776 | ||
| The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. | Q35740186 | ||
| Application of human leukocyte antigen-G expression in the diagnosis of human cancer | Q35867466 | ||
| Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? | Q36184793 | ||
| Functions of HLA-G in the immune system. | Q36795981 | ||
| Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). | Q36943220 | ||
| Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). | Q36943225 | ||
| Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer | Q37293938 | ||
| Human leukocyte antigen-G in cancer: are they clinically relevant? | Q37917992 | ||
| Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance | Q40422790 | ||
| HLA-G gene activation in tumor cells involves cis-acting epigenetic changes | Q40498365 | ||
| Cytokines and gene therapy | Q40515608 | ||
| Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts | Q42832178 | ||
| The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells | Q46963129 | ||
| Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications | Q50417083 | ||
| Evidence of balancing selection at the HLA-G promoter region. | Q52841198 | ||
| Human histocompatibility proteins. | Q53420957 | ||
| Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer | Q80730549 | ||
| HLA-G and cancer | Q80795261 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 613-619 | |
| P577 | publication date | 2015-02-28 | |
| P1433 | published in | Thoracic Cancer | Q26842004 |
| P1476 | title | Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer | |
| P478 | volume | 6 |
| Q64926910 | Association between AKT rs2494752 single nucleotide polymorphism and the risk of metastasis in hepatocellular carcinoma. |
| Q36102549 | Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage |
| Q89857359 | Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p |
| Q64994489 | MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer. |
| Q56518219 | Prognostic role of snail in lung cancer: Protocol for a systematic review |
Search more.